Srikumar Chellappan

9.6k citations
108 papers · 7.9k · 3 hit papers · h-index 46

Impact in

  • Oncology top 0.5%
    • Cancer-related Molecular Pathways
    • Epigenetics and DNA Methylation
    • Nicotinic Acetylcholine Receptors Study
    • Ubiquitin and proteasome pathways
    • RNA modifications and cancer
    • Genomics and Chromatin Dynamics

Papers in

    • Ubiquitin and proteasome pathways 18
    • Nicotinic Acetylcholine Receptors Study 13
    • Genomics and Chromatin Dynamics 10
    • Epigenetics and DNA Methylation 9
    • Retinoids in leukemia and cellular processes 7
    • Cancer-related Molecular Pathways 42
    • Cancer Cells and Metastasis 7

Srikumar Chellappan

106 papers receiving 7.8k citations

Srikumar Chellappan's Hit Papers

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. 1992 · 516 citations
5160+11+23Years since publication4008001.2k

Peers

Srikumar Chellappan
Comparison fields: 5 of 130
  • Oncology 3.2k
  • Molecular Biology 5.1k
  • Cancer Research 963
  • Ophthalmology 443
  • Cell Biology 675
Replace Grazia Ambrosini with:
Grazia Ambrosini United States
Chuan‐Yuan Li United States
Qiang Yu Singapore
Jason D. Weber United States
Vjekoslav Dulić France
Masatoshi Kitagawa Japan
W. Douglas Cress United States
Alfonso Bellacosa United States
Hallgeir Rui United States
Joanna Roberts United States
Srikumar Chellappan relative to Grazia Ambrosini United States Grazia Ambrosini's profile →
Citations per field
00.5×
Grazia Ambrosini · 1×
Citations per year

Countries citing papers authored by Srikumar Chellappan

Since Specialization
Citations

This map shows the geographic impact of Srikumar Chellappan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srikumar Chellappan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srikumar Chellappan more than expected).

Fields of papers citing papers by Srikumar Chellappan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srikumar Chellappan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srikumar Chellappan. The network helps show where Srikumar Chellappan may publish in the future.

Co-authors

The 25 scholars most cited alongside Srikumar Chellappan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Srikumar Chellappan Line = papers co-authored together Srikumar Chellappan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The E2F transcription factor is a cellular target for the RB protein
Hit paper breakdown →
19911209
2
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
Hit paper breakdown →
1992516
3
Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Hit paper breakdown →
1992502
4 2008319
5 2014272
6 2006249
7 2012212
8 1993207
9 1999197
10 2002183
11 2009155
12 1999140
13 2015138
14 2006129
15 2011119
16 2018117
17 2012112
18 1998106
19 2015101
20 199891

About Srikumar Chellappan

Srikumar Chellappan is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Immunology, having authored 108 papers that have together received 7.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (42 papers), Ubiquitin and proteasome pathways (18 papers), Microtubule and mitosis dynamics (14 papers), Nicotinic Acetylcholine Receptors Study (13 papers), Genomics and Chromatin Dynamics (10 papers), Epigenetics and DNA Methylation (9 papers), Retinoids in leukemia and cellular processes (7 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Oncology (3.2k citations), Molecular Biology (5.1k citations), Cancer Research (963 citations), Ophthalmology (443 citations) and Cell Biology (675 citations). Srikumar Chellappan has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Joseph R. Nevins, Scott W. Hiebert, Maria Mudryj, Jonathan M. Horowitz, Courtney Schaal, Smitha Pillai, Piyali Dasgupta, Eric B. Haura, Sandeep Singh and Domenico Coppola. Their work appears in journals such as Cancer Research, Oncogene, Molecular and Cellular Biology, PLoS ONE and Molecular Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact